本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.7322
-0.0156-2.09%
盘后0.7200-0.0122-1.67%16:53 EDT
成交量:6.71万
成交额:4.99万
市值:545.02万
市盈率:-0.07
高:0.7650
开:0.7254
低:0.7250
收:0.7478
数据加载中...
2022/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report
2022/06/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report
2022/06/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/09

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/29

重要事件披露

8-K - Current report